img

Global Personalized Cell Therapeutic Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Personalized Cell Therapeutic Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Personalized cells are undifferentiated stem cells that can be divided to generate offspring cells designated as specialized or personalized stem cells. Specialized treatment of numerous chronic diseases such as autoimmune and cancer through vaccinating living cells into the body of patients to boost the personalized cell therapy market. As there are multiple types of living cells such as immature and mature living cell, blood and bone marrow cell and embryonic stem cells that are mainly utilized in personalized cell therapy.
Personalized Cell Therapeutic report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Personalized Cell Therapeutic market is projected to reach US$ 26100 million in 2033, increasing from US$ 12570 million in 2022, with the CAGR of 11.0% during the period of 2023 to 2033. Demand from Cardiovascular Diseases and Neurological Disorders are the major drivers for the industry.
Several manufacturers are conducting numerous clinical trials to develop new personalized cell therapies for chronic diseases such as cancer, diabetes and other autoimmune diseases. For example, in April 2019, Orgenesis Inc. received approval from the Institutional Review Board (IRB) to collect liver biopsy samples from patients at the Rambam Medical Center in Israel. Samples were collected to confirm the safety and efficacy of hepatocytes for individualized cell replacement therapy in patients with insulin-dependent diabetes mellitus following total or partial pancreatectomy. Hence, increasing number of studies is expected to boost the growth of the global personalized cell therapy market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Personalized Cell Therapeutic market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


AbbVie Inc
Bausch Health Companies Inc
Teva Pharmaceutical Industries Ltd
Cipla
Lupin
Sun Pharmaceuticals Industries Ltd
Hikma Pharmaceuticals PLC
AstraZeneca
GSK Plc
Pfizer Inc
Amneal Pharmaceuticals LLC
Alvogen
F. Hoffmann-La Roche Ltd
Amgen Inc
Jazz Pharmaceuticals, Inc
Amicus Therapeutics, Inc
MeiraGTx Limited
Rocket Pharmaceuticals, Inc
Gilead Sciences, Inc
Segment by Type
Embryonic Stem Cells
Adult Stem Cell
Induced Pluripotent Cells
Other

Segment by Application


Cardiovascular Diseases
Neurological Disorders
Diabetes
Oncology
Other

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Personalized Cell Therapeutic market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Personalized Cell Therapeutic, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Personalized Cell Therapeutic industry.
Chapter 3Historical (2018-2022) and forecast (2023-2033) volume and revenue analysis of Personalized Cell Therapeutic in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Personalized Cell Therapeutic introduction, etc. Personalized Cell Therapeutic Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13MRAResearch’s Conclusions of Personalized Cell Therapeutic market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by MRAResearch.

Table of Content

1 Personalized Cell Therapeutic Market Overview
1.1 Personalized Cell Therapeutic Product Overview
1.2 Personalized Cell Therapeutic Market Segment by Type
1.2.1 Embryonic Stem Cells
1.2.2 Adult Stem Cell
1.2.3 Induced Pluripotent Cells
1.2.4 Other
1.3 Global Personalized Cell Therapeutic Market Size by Type
1.3.1 Global Personalized Cell Therapeutic Market Size Overview by Type (2018-2033)
1.3.2 Global Personalized Cell Therapeutic Historic Market Size Review by Type (2018-2023)
1.3.3 Global Personalized Cell Therapeutic Forecasted Market Size by Type (2024-2033)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Personalized Cell Therapeutic Sales Breakdown by Type (2018-2023)
1.4.2 Europe Personalized Cell Therapeutic Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Personalized Cell Therapeutic Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Personalized Cell Therapeutic Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Personalized Cell Therapeutic Sales Breakdown by Type (2018-2023)
2 Global Personalized Cell Therapeutic Market Competition by Company
2.1 Global Top Players by Personalized Cell Therapeutic Sales (2018-2023)
2.2 Global Top Players by Personalized Cell Therapeutic Revenue (2018-2023)
2.3 Global Top Players by Personalized Cell Therapeutic Price (2018-2023)
2.4 Global Top Manufacturers Personalized Cell Therapeutic Manufacturing Base Distribution, Sales Area, Product Type
2.5 Personalized Cell Therapeutic Market Competitive Situation and Trends
2.5.1 Personalized Cell Therapeutic Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Personalized Cell Therapeutic Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Personalized Cell Therapeutic as of 2022)
2.7 Date of Key Manufacturers Enter into Personalized Cell Therapeutic Market
2.8 Key Manufacturers Personalized Cell Therapeutic Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Personalized Cell Therapeutic Status and Outlook by Region
3.1 Global Personalized Cell Therapeutic Market Size and CAGR by Region: 2018 VS 2022 VS 2033
3.2 Global Personalized Cell Therapeutic Historic Market Size by Region
3.2.1 Global Personalized Cell Therapeutic Sales in Volume by Region (2018-2023)
3.2.2 Global Personalized Cell Therapeutic Sales in Value by Region (2018-2023)
3.2.3 Global Personalized Cell Therapeutic Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Personalized Cell Therapeutic Forecasted Market Size by Region
3.3.1 Global Personalized Cell Therapeutic Sales in Volume by Region (2024-2033)
3.3.2 Global Personalized Cell Therapeutic Sales in Value by Region (2024-2033)
3.3.3 Global Personalized Cell Therapeutic Sales (Volume & Value), Price and Gross Margin (2024-2033)
4 Global Personalized Cell Therapeutic by Application
4.1 Personalized Cell Therapeutic Market Segment by Application
4.1.1 Cardiovascular Diseases
4.1.2 Neurological Disorders
4.1.3 Diabetes
4.1.4 Oncology
4.1.5 Other
4.2 Global Personalized Cell Therapeutic Market Size by Application
4.2.1 Global Personalized Cell Therapeutic Market Size Overview by Application (2018-2033)
4.2.2 Global Personalized Cell Therapeutic Historic Market Size Review by Application (2018-2023)
4.2.3 Global Personalized Cell Therapeutic Forecasted Market Size by Application (2024-2033)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Personalized Cell Therapeutic Sales Breakdown by Application (2018-2023)
4.3.2 Europe Personalized Cell Therapeutic Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Personalized Cell Therapeutic Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Personalized Cell Therapeutic Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Personalized Cell Therapeutic Sales Breakdown by Application (2018-2023)
5 North America Personalized Cell Therapeutic by Country
5.1 North America Personalized Cell Therapeutic Historic Market Size by Country
5.1.1 North America Personalized Cell Therapeutic Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2033
5.1.2 North America Personalized Cell Therapeutic Sales in Volume by Country (2018-2023)
5.1.3 North America Personalized Cell Therapeutic Sales in Value by Country (2018-2023)
5.2 North America Personalized Cell Therapeutic Forecasted Market Size by Country
5.2.1 North America Personalized Cell Therapeutic Sales in Volume by Country (2024-2033)
5.2.2 North America Personalized Cell Therapeutic Sales in Value by Country (2024-2033)
6 Europe Personalized Cell Therapeutic by Country
6.1 Europe Personalized Cell Therapeutic Historic Market Size by Country
6.1.1 Europe Personalized Cell Therapeutic Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2033
6.1.2 Europe Personalized Cell Therapeutic Sales in Volume by Country (2018-2023)
6.1.3 Europe Personalized Cell Therapeutic Sales in Value by Country (2018-2023)
6.2 Europe Personalized Cell Therapeutic Forecasted Market Size by Country
6.2.1 Europe Personalized Cell Therapeutic Sales in Volume by Country (2024-2033)
6.2.2 Europe Personalized Cell Therapeutic Sales in Value by Country (2024-2033)
7 Asia-Pacific Personalized Cell Therapeutic by Region
7.1 Asia-Pacific Personalized Cell Therapeutic Historic Market Size by Region
7.1.1 Asia-Pacific Personalized Cell Therapeutic Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2033
7.1.2 Asia-Pacific Personalized Cell Therapeutic Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Personalized Cell Therapeutic Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Personalized Cell Therapeutic Forecasted Market Size by Region
7.2.1 Asia-Pacific Personalized Cell Therapeutic Sales in Volume by Region (2024-2033)
7.2.2 Asia-Pacific Personalized Cell Therapeutic Sales in Value by Region (2024-2033)
8 Latin America Personalized Cell Therapeutic by Country
8.1 Latin America Personalized Cell Therapeutic Historic Market Size by Country
8.1.1 Latin America Personalized Cell Therapeutic Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2033
8.1.2 Latin America Personalized Cell Therapeutic Sales in Volume by Country (2018-2023)
8.1.3 Latin America Personalized Cell Therapeutic Sales in Value by Country (2018-2023)
8.2 Latin America Personalized Cell Therapeutic Forecasted Market Size by Country
8.2.1 Latin America Personalized Cell Therapeutic Sales in Volume by Country (2024-2033)
8.2.2 Latin America Personalized Cell Therapeutic Sales in Value by Country (2024-2033)
9 Middle East and Africa Personalized Cell Therapeutic by Country
9.1 Middle East and Africa Personalized Cell Therapeutic Historic Market Size by Country
9.1.1 Middle East and Africa Personalized Cell Therapeutic Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2033
9.1.2 Middle East and Africa Personalized Cell Therapeutic Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Personalized Cell Therapeutic Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Personalized Cell Therapeutic Forecasted Market Size by Country
9.2.1 Middle East and Africa Personalized Cell Therapeutic Sales in Volume by Country (2024-2033)
9.2.2 Middle East and Africa Personalized Cell Therapeutic Sales in Value by Country (2024-2033)
10 Company Profiles
10.1 AbbVie Inc
10.1.1 AbbVie Inc Company Information
10.1.2 AbbVie Inc Introduction and Business Overview
10.1.3 AbbVie Inc Personalized Cell Therapeutic Sales, Revenue and Gross Margin (2018-2023)
10.1.4 AbbVie Inc Personalized Cell Therapeutic Products Offered
10.1.5 AbbVie Inc Recent Development
10.2 Bausch Health Companies Inc
10.2.1 Bausch Health Companies Inc Company Information
10.2.2 Bausch Health Companies Inc Introduction and Business Overview
10.2.3 Bausch Health Companies Inc Personalized Cell Therapeutic Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Bausch Health Companies Inc Personalized Cell Therapeutic Products Offered
10.2.5 Bausch Health Companies Inc Recent Development
10.3 Teva Pharmaceutical Industries Ltd
10.3.1 Teva Pharmaceutical Industries Ltd Company Information
10.3.2 Teva Pharmaceutical Industries Ltd Introduction and Business Overview
10.3.3 Teva Pharmaceutical Industries Ltd Personalized Cell Therapeutic Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Teva Pharmaceutical Industries Ltd Personalized Cell Therapeutic Products Offered
10.3.5 Teva Pharmaceutical Industries Ltd Recent Development
10.4 Cipla
10.4.1 Cipla Company Information
10.4.2 Cipla Introduction and Business Overview
10.4.3 Cipla Personalized Cell Therapeutic Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Cipla Personalized Cell Therapeutic Products Offered
10.4.5 Cipla Recent Development
10.5 Lupin
10.5.1 Lupin Company Information
10.5.2 Lupin Introduction and Business Overview
10.5.3 Lupin Personalized Cell Therapeutic Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Lupin Personalized Cell Therapeutic Products Offered
10.5.5 Lupin Recent Development
10.6 Sun Pharmaceuticals Industries Ltd
10.6.1 Sun Pharmaceuticals Industries Ltd Company Information
10.6.2 Sun Pharmaceuticals Industries Ltd Introduction and Business Overview
10.6.3 Sun Pharmaceuticals Industries Ltd Personalized Cell Therapeutic Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Sun Pharmaceuticals Industries Ltd Personalized Cell Therapeutic Products Offered
10.6.5 Sun Pharmaceuticals Industries Ltd Recent Development
10.7 Hikma Pharmaceuticals PLC
10.7.1 Hikma Pharmaceuticals PLC Company Information
10.7.2 Hikma Pharmaceuticals PLC Introduction and Business Overview
10.7.3 Hikma Pharmaceuticals PLC Personalized Cell Therapeutic Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Hikma Pharmaceuticals PLC Personalized Cell Therapeutic Products Offered
10.7.5 Hikma Pharmaceuticals PLC Recent Development
10.8 AstraZeneca
10.8.1 AstraZeneca Company Information
10.8.2 AstraZeneca Introduction and Business Overview
10.8.3 AstraZeneca Personalized Cell Therapeutic Sales, Revenue and Gross Margin (2018-2023)
10.8.4 AstraZeneca Personalized Cell Therapeutic Products Offered
10.8.5 AstraZeneca Recent Development
10.9 GSK Plc
10.9.1 GSK Plc Company Information
10.9.2 GSK Plc Introduction and Business Overview
10.9.3 GSK Plc Personalized Cell Therapeutic Sales, Revenue and Gross Margin (2018-2023)
10.9.4 GSK Plc Personalized Cell Therapeutic Products Offered
10.9.5 GSK Plc Recent Development
10.10 Pfizer Inc
10.10.1 Pfizer Inc Company Information
10.10.2 Pfizer Inc Introduction and Business Overview
10.10.3 Pfizer Inc Personalized Cell Therapeutic Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Pfizer Inc Personalized Cell Therapeutic Products Offered
10.10.5 Pfizer Inc Recent Development
10.11 Amneal Pharmaceuticals LLC
10.11.1 Amneal Pharmaceuticals LLC Company Information
10.11.2 Amneal Pharmaceuticals LLC Introduction and Business Overview
10.11.3 Amneal Pharmaceuticals LLC Personalized Cell Therapeutic Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Amneal Pharmaceuticals LLC Personalized Cell Therapeutic Products Offered
10.11.5 Amneal Pharmaceuticals LLC Recent Development
10.12 Alvogen
10.12.1 Alvogen Company Information
10.12.2 Alvogen Introduction and Business Overview
10.12.3 Alvogen Personalized Cell Therapeutic Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Alvogen Personalized Cell Therapeutic Products Offered
10.12.5 Alvogen Recent Development
10.13 F. Hoffmann-La Roche Ltd
10.13.1 F. Hoffmann-La Roche Ltd Company Information
10.13.2 F. Hoffmann-La Roche Ltd Introduction and Business Overview
10.13.3 F. Hoffmann-La Roche Ltd Personalized Cell Therapeutic Sales, Revenue and Gross Margin (2018-2023)
10.13.4 F. Hoffmann-La Roche Ltd Personalized Cell Therapeutic Products Offered
10.13.5 F. Hoffmann-La Roche Ltd Recent Development
10.14 Amgen Inc
10.14.1 Amgen Inc Company Information
10.14.2 Amgen Inc Introduction and Business Overview
10.14.3 Amgen Inc Personalized Cell Therapeutic Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Amgen Inc Personalized Cell Therapeutic Products Offered
10.14.5 Amgen Inc Recent Development
10.15 Jazz Pharmaceuticals, Inc
10.15.1 Jazz Pharmaceuticals, Inc Company Information
10.15.2 Jazz Pharmaceuticals, Inc Introduction and Business Overview
10.15.3 Jazz Pharmaceuticals, Inc Personalized Cell Therapeutic Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Jazz Pharmaceuticals, Inc Personalized Cell Therapeutic Products Offered
10.15.5 Jazz Pharmaceuticals, Inc Recent Development
10.16 Amicus Therapeutics, Inc
10.16.1 Amicus Therapeutics, Inc Company Information
10.16.2 Amicus Therapeutics, Inc Introduction and Business Overview
10.16.3 Amicus Therapeutics, Inc Personalized Cell Therapeutic Sales, Revenue and Gross Margin (2018-2023)
10.16.4 Amicus Therapeutics, Inc Personalized Cell Therapeutic Products Offered
10.16.5 Amicus Therapeutics, Inc Recent Development
10.17 MeiraGTx Limited
10.17.1 MeiraGTx Limited Company Information
10.17.2 MeiraGTx Limited Introduction and Business Overview
10.17.3 MeiraGTx Limited Personalized Cell Therapeutic Sales, Revenue and Gross Margin (2018-2023)
10.17.4 MeiraGTx Limited Personalized Cell Therapeutic Products Offered
10.17.5 MeiraGTx Limited Recent Development
10.18 Rocket Pharmaceuticals, Inc
10.18.1 Rocket Pharmaceuticals, Inc Company Information
10.18.2 Rocket Pharmaceuticals, Inc Introduction and Business Overview
10.18.3 Rocket Pharmaceuticals, Inc Personalized Cell Therapeutic Sales, Revenue and Gross Margin (2018-2023)
10.18.4 Rocket Pharmaceuticals, Inc Personalized Cell Therapeutic Products Offered
10.18.5 Rocket Pharmaceuticals, Inc Recent Development
10.19 Gilead Sciences, Inc
10.19.1 Gilead Sciences, Inc Company Information
10.19.2 Gilead Sciences, Inc Introduction and Business Overview
10.19.3 Gilead Sciences, Inc Personalized Cell Therapeutic Sales, Revenue and Gross Margin (2018-2023)
10.19.4 Gilead Sciences, Inc Personalized Cell Therapeutic Products Offered
10.19.5 Gilead Sciences, Inc Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Personalized Cell Therapeutic Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Personalized Cell Therapeutic Industrial Chain Analysis
11.4 Personalized Cell Therapeutic Market Dynamics
11.4.1 Personalized Cell Therapeutic Industry Trends
11.4.2 Personalized Cell Therapeutic Market Drivers
11.4.3 Personalized Cell Therapeutic Market Challenges
11.4.4 Personalized Cell Therapeutic Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Personalized Cell Therapeutic Distributors
12.3 Personalized Cell Therapeutic Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Embryonic Stem Cells
Table 2. Major Company of Adult Stem Cell
Table 3. Major Company of Induced Pluripotent Cells
Table 4. Major Company of Other
Table 5. Global Personalized Cell Therapeutic Sales by Type 2018 VS 2022 VS 2033 (US$ Million)
Table 6. Global Personalized Cell Therapeutic Sales by Type (2018-2023) & (K Units)
Table 7. Global Personalized Cell Therapeutic Sales Market Share in Volume by Type (2018-2023)
Table 8. Global Personalized Cell Therapeutic Sales by Type (2018-2023) & (US& Million)
Table 9. Global Personalized Cell Therapeutic Market Share in Value by Type (2018-2023)
Table 10. Global Personalized Cell Therapeutic Price by Type (2018-2023) & (US$/Unit)
Table 11. Global Personalized Cell Therapeutic Sales by Type (2024-2033) & (K Units)
Table 12. Global Personalized Cell Therapeutic Sales Market Share in Volume by Type (2024-2033)
Table 13. Global Personalized Cell Therapeutic Sales by Type (2024-2033) & (US$ Million)
Table 14. Global Personalized Cell Therapeutic Sales Market Share in Value by Type (2024-2033)
Table 15. Global Personalized Cell Therapeutic Price by Type (2024-2033) & (US$/Unit)
Table 16. North America Personalized Cell Therapeutic Sales by Type (2018-2023) & (K Units)
Table 17. North America Personalized Cell Therapeutic Sales by Type (2018-2023) & (US$ Million)
Table 18. Europe Personalized Cell Therapeutic Sales (K Units) by Type (2018-2023)
Table 19. Europe Personalized Cell Therapeutic Sales by Type (2018-2023) & (US$ Million)
Table 20. Asia-Pacific Personalized Cell Therapeutic Sales (K Units) by Type (2018-2023)
Table 21. Asia-Pacific Personalized Cell Therapeutic Sales by Type (2018-2023) & (US$ Million)
Table 22. Latin America Personalized Cell Therapeutic Sales (K Units) by Type (2018-2023)
Table 23. Latin America Personalized Cell Therapeutic Sales by Type (2018-2023) & (US$ Million)
Table 24. Middle East and Africa Personalized Cell Therapeutic Sales (K Units) by Type (2018-2023)
Table 25. Middle East and Africa Personalized Cell Therapeutic Sales by Type (2018-2023) & (US$ Million)
Table 26. Global Personalized Cell Therapeutic Sales by Company (2018-2023) & (K Units)
Table 27. Global Personalized Cell Therapeutic Sales Share by Company (2018-2023)
Table 28. Global Personalized Cell Therapeutic Revenue by Company (2018-2023) & (US$ Million)
Table 29. Global Personalized Cell Therapeutic Revenue Share by Company (2018-2023)
Table 30. Global Market Personalized Cell Therapeutic Price by Company (2018-2023) & (US$/Unit)
Table 31. Global Personalized Cell Therapeutic Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global Personalized Cell Therapeutic Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Personalized Cell Therapeutic as of 2022)
Table 34. Date of Key Manufacturers Enter into Personalized Cell Therapeutic Market
Table 35. Key Manufacturers Personalized Cell Therapeutic Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Personalized Cell Therapeutic Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Global Personalized Cell Therapeutic Sales by Region (2018-2023) & (K Units)
Table 39. Global Personalized Cell Therapeutic Sales Market Share in Volume by Region (2018-2023)
Table 40. Global Personalized Cell Therapeutic Sales by Region (2018-2023) & (US$ Million)
Table 41. Global Personalized Cell Therapeutic Sales Market Share in Value by Region (2018-2023)
Table 42. Global Personalized Cell Therapeutic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 43. Global Personalized Cell Therapeutic Sales by Region (2024-2033) & (K Units)
Table 44. Global Personalized Cell Therapeutic Sales Market Share in Volume by Region (2024-2033)
Table 45. Global Personalized Cell Therapeutic Sales by Region (2024-2033) & (US$ Million)
Table 46. Global Personalized Cell Therapeutic Sales Market Share in Value by Region (2024-2033)
Table 47. Global Personalized Cell Therapeutic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2033)
Table 48. Global Personalized Cell Therapeutic Sales by Application: 2018 VS 2022 VS 2033 (US$ Million)
Table 49. Global Personalized Cell Therapeutic Sales by Application (2018-2023) & (K Units)
Table 50. Global Personalized Cell Therapeutic Sales Market Share in Volume by Application (2018-2023)
Table 51. Global Personalized Cell Therapeutic Sales by Application (2018-2023) & (US$ Million)
Table 52. Global Personalized Cell Therapeutic Sales Market Share in Value by Application (2018-2023)
Table 53. Global Personalized Cell Therapeutic Price by Application (2018-2023) & (US$/Unit)
Table 54. Global Personalized Cell Therapeutic Sales by Application (2024-2033) & (K Units)
Table 55. Global Personalized Cell Therapeutic Sales Market Share in Volume by Application (2024-2033)
Table 56. Global Personalized Cell Therapeutic Sales by Application (2024-2033) & (US$ Million)
Table 57. Global Personalized Cell Therapeutic Sales Market Share in Value by Application (2024-2033)
Table 58. Global Personalized Cell Therapeutic Price by Application (2024-2033) & (US$/Unit)
Table 59. North America Personalized Cell Therapeutic Sales by Application (2018-2023) (K Units)
Table 60. North America Personalized Cell Therapeutic Sales by Application (2018-2023) & (US$ Million)
Table 61. Europe Personalized Cell Therapeutic Sales by Application (2018-2023) (K Units)
Table 62. Europe Personalized Cell Therapeutic Sales by Application (2018-2023) & (US$ Million)
Table 63. Asia-Pacific Personalized Cell Therapeutic Sales by Application (2018-2023) (K Units)
Table 64. Asia-Pacific Personalized Cell Therapeutic Sales by Application (2018-2023) & (US$ Million)
Table 65. Latin America Personalized Cell Therapeutic Sales by Application (2018-2023) (K Units)
Table 66. Latin America Personalized Cell Therapeutic Sales by Application (2018-2023) & (US$ Million)
Table 67. Middle East and Africa Personalized Cell Therapeutic Sales by Application (2018-2023) (K Units)
Table 68. Middle East and Africa Personalized Cell Therapeutic Sales by Application (2018-2023) & (US$ Million)
Table 69. North America Personalized Cell Therapeutic Sales by Country (2018-2023) & (K Units)
Table 70. North America Personalized Cell Therapeutic Sales Market Share in Volume by Country (2018-2023)
Table 71. North America Personalized Cell Therapeutic Sales by Country (2018-2023) & (US$ Million)
Table 72. North America Personalized Cell Therapeutic Sales Market Share in Value by Country (2018-2023)
Table 73. North America Personalized Cell Therapeutic Sales by Country (2024-2033) & (K Units)
Table 74. North America Personalized Cell Therapeutic Sales Market Share in Volume by Country (2024-2033)
Table 75. North America Personalized Cell Therapeutic Sales by Country (2024-2033) & (US$ Million)
Table 76. North America Personalized Cell Therapeutic Sales Market Share in Value by Country (2024-2033)
Table 77. Europe Personalized Cell Therapeutic Sales by Country (2018-2023) & (K Units)
Table 78. Europe Personalized Cell Therapeutic Sales Market Share in Volume by Country (2018-2023)
Table 79. Europe Personalized Cell Therapeutic Sales by Country (2018-2023) & (US$ Million)
Table 80. Europe Personalized Cell Therapeutic Sales Market Share in Value by Country (2018-2023)
Table 81. Europe Personalized Cell Therapeutic Sales by Country (2024-2033) & (K Units)
Table 82. Europe Personalized Cell Therapeutic Sales Market Share in Volume by Country (2024-2033)
Table 83. Europe Personalized Cell Therapeutic Sales by Country (2024-2033) & (US$ Million)
Table 84. Europe Personalized Cell Therapeutic Sales Market Share in Value by Country (2024-2033)
Table 85. Asia-Pacific Personalized Cell Therapeutic Sales by Region (2018-2023) & (K Units)
Table 86. Asia-Pacific Personalized Cell Therapeutic Sales Market Share in Volume by Region (2018-2023)
Table 87. Asia-Pacific Personalized Cell Therapeutic Sales by Region (2018-2023) & (US$ Million)
Table 88. Asia-Pacific Personalized Cell Therapeutic Sales Market Share in Value by Region (2018-2023)
Table 89. Asia-Pacific Personalized Cell Therapeutic Sales by Region (2024-2033) & (K Units)
Table 90. Asia-Pacific Personalized Cell Therapeutic Sales Market Share in Volume by Region (2024-2033)
Table 91. Asia-Pacific Personalized Cell Therapeutic Sales by Region (2024-2033) & (US$ Million)
Table 92. Asia-Pacific Personalized Cell Therapeutic Sales Market Share in Value by Region (2024-2033)
Table 93. Latin America Personalized Cell Therapeutic Sales by Country (2018-2023) & (K Units)
Table 94. Latin America Personalized Cell Therapeutic Sales Market Share in Volume by Country (2018-2023)
Table 95. Latin America Personalized Cell Therapeutic Sales by Country (2018-2023) & (US$ Million)
Table 96. Latin America Personalized Cell Therapeutic Sales Market Share in Value by Country (2018-2023)
Table 97. Latin America Personalized Cell Therapeutic Sales by Country (2024-2033) & (K Units)
Table 98. Latin America Personalized Cell Therapeutic Sales Market Share in Volume by Country (2024-2033)
Table 99. Latin America Personalized Cell Therapeutic Sales by Country (2024-2033) & (US$ Million)
Table 100. Latin America Personalized Cell Therapeutic Sales Market Share in Value by Country (2024-2033)
Table 101. Middle East and Africa Personalized Cell Therapeutic Sales by Country (2018-2023) & (K Units)
Table 102. Middle East and Africa Personalized Cell Therapeutic Sales Market Share in Volume by Country (2018-2023)
Table 103. Middle East and Africa Personalized Cell Therapeutic Sales by Country (2018-2023) & (US$ Million)
Table 104. Middle East and Africa Personalized Cell Therapeutic Sales Market Share in Value by Country (2018-2023)
Table 105. Middle East and Africa Personalized Cell Therapeutic Sales by Country (2024-2033) & (K Units)
Table 106. Middle East and Africa Personalized Cell Therapeutic Sales Market Share in Volume by Country (2024-2033)
Table 107. Middle East and Africa Personalized Cell Therapeutic Sales by Country (2024-2033) & (US$ Million)
Table 108. Middle East and Africa Personalized Cell Therapeutic Sales Market Share in Value by Country (2024-2033)
Table 109. AbbVie Inc Company Information
Table 110. AbbVie Inc Introduction and Business Overview
Table 111. AbbVie Inc Personalized Cell Therapeutic Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 112. AbbVie Inc Personalized Cell Therapeutic Product
Table 113. AbbVie Inc Recent Development
Table 114. Bausch Health Companies Inc Company Information
Table 115. Bausch Health Companies Inc Introduction and Business Overview
Table 116. Bausch Health Companies Inc Personalized Cell Therapeutic Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 117. Bausch Health Companies Inc Personalized Cell Therapeutic Product
Table 118. Bausch Health Companies Inc Recent Development
Table 119. Teva Pharmaceutical Industries Ltd Company Information
Table 120. Teva Pharmaceutical Industries Ltd Introduction and Business Overview
Table 121. Teva Pharmaceutical Industries Ltd Personalized Cell Therapeutic Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 122. Teva Pharmaceutical Industries Ltd Personalized Cell Therapeutic Product
Table 123. Teva Pharmaceutical Industries Ltd Recent Development
Table 124. Cipla Company Information
Table 125. Cipla Introduction and Business Overview
Table 126. Cipla Personalized Cell Therapeutic Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 127. Cipla Personalized Cell Therapeutic Product
Table 128. Cipla Recent Development
Table 129. Lupin Company Information
Table 130. Lupin Introduction and Business Overview
Table 131. Lupin Personalized Cell Therapeutic Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 132. Lupin Personalized Cell Therapeutic Product
Table 133. Lupin Recent Development
Table 134. Sun Pharmaceuticals Industries Ltd Company Information
Table 135. Sun Pharmaceuticals Industries Ltd Introduction and Business Overview
Table 136. Sun Pharmaceuticals Industries Ltd Personalized Cell Therapeutic Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 137. Sun Pharmaceuticals Industries Ltd Personalized Cell Therapeutic Product
Table 138. Sun Pharmaceuticals Industries Ltd Recent Development
Table 139. Hikma Pharmaceuticals PLC Company Information
Table 140. Hikma Pharmaceuticals PLC Introduction and Business Overview
Table 141. Hikma Pharmaceuticals PLC Personalized Cell Therapeutic Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 142. Hikma Pharmaceuticals PLC Personalized Cell Therapeutic Product
Table 143. Hikma Pharmaceuticals PLC Recent Development
Table 144. AstraZeneca Company Information
Table 145. AstraZeneca Introduction and Business Overview
Table 146. AstraZeneca Personalized Cell Therapeutic Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 147. AstraZeneca Personalized Cell Therapeutic Product
Table 148. AstraZeneca Recent Development
Table 149. GSK Plc Company Information
Table 150. GSK Plc Introduction and Business Overview
Table 151. GSK Plc Personalized Cell Therapeutic Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 152. GSK Plc Personalized Cell Therapeutic Product
Table 153. GSK Plc Recent Development
Table 154. Pfizer Inc Company Information
Table 155. Pfizer Inc Introduction and Business Overview
Table 156. Pfizer Inc Personalized Cell Therapeutic Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 157. Pfizer Inc Personalized Cell Therapeutic Product
Table 158. Pfizer Inc Recent Development
Table 159. Amneal Pharmaceuticals LLC Company Information
Table 160. Amneal Pharmaceuticals LLC Introduction and Business Overview
Table 161. Amneal Pharmaceuticals LLC Personalized Cell Therapeutic Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 162. Amneal Pharmaceuticals LLC Personalized Cell Therapeutic Product
Table 163. Amneal Pharmaceuticals LLC Recent Development
Table 164. Alvogen Company Information
Table 165. Alvogen Introduction and Business Overview
Table 166. Alvogen Personalized Cell Therapeutic Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 167. Alvogen Personalized Cell Therapeutic Product
Table 168. Alvogen Recent Development
Table 169. F. Hoffmann-La Roche Ltd Company Information
Table 170. F. Hoffmann-La Roche Ltd Introduction and Business Overview
Table 171. F. Hoffmann-La Roche Ltd Personalized Cell Therapeutic Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 172. F. Hoffmann-La Roche Ltd Personalized Cell Therapeutic Product
Table 173. F. Hoffmann-La Roche Ltd Recent Development
Table 174. Amgen Inc Company Information
Table 175. Amgen Inc Introduction and Business Overview
Table 176. Amgen Inc Personalized Cell Therapeutic Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 177. Amgen Inc Personalized Cell Therapeutic Product
Table 178. Amgen Inc Recent Development
Table 179. Jazz Pharmaceuticals, Inc Company Information
Table 180. Jazz Pharmaceuticals, Inc Introduction and Business Overview
Table 181. Jazz Pharmaceuticals, Inc Personalized Cell Therapeutic Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 182. Jazz Pharmaceuticals, Inc Personalized Cell Therapeutic Product
Table 183. Jazz Pharmaceuticals, Inc Recent Development
Table 184. Amicus Therapeutics, Inc Company Information
Table 185. Amicus Therapeutics, Inc Introduction and Business Overview
Table 186. Amicus Therapeutics, Inc Personalized Cell Therapeutic Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 187. Amicus Therapeutics, Inc Personalized Cell Therapeutic Product
Table 188. Amicus Therapeutics, Inc Recent Development
Table 189. MeiraGTx Limited Company Information
Table 190. MeiraGTx Limited Introduction and Business Overview
Table 191. MeiraGTx Limited Personalized Cell Therapeutic Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 192. MeiraGTx Limited Personalized Cell Therapeutic Product
Table 193. MeiraGTx Limited Recent Development
Table 194. Rocket Pharmaceuticals, Inc Company Information
Table 195. Rocket Pharmaceuticals, Inc Introduction and Business Overview
Table 196. Rocket Pharmaceuticals, Inc Personalized Cell Therapeutic Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 197. Rocket Pharmaceuticals, Inc Personalized Cell Therapeutic Product
Table 198. Rocket Pharmaceuticals, Inc Recent Development
Table 199. Gilead Sciences, Inc Company Information
Table 200. Gilead Sciences, Inc Introduction and Business Overview
Table 201. Gilead Sciences, Inc Personalized Cell Therapeutic Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 202. Gilead Sciences, Inc Personalized Cell Therapeutic Product
Table 203. Gilead Sciences, Inc Recent Development
Table 204. Key Raw Materials Lists
Table 205. Raw Materials Key Suppliers Lists
Table 206. Personalized Cell Therapeutic Market Trends
Table 207. Personalized Cell Therapeutic Market Drivers
Table 208. Personalized Cell Therapeutic Market Challenges
Table 209. Personalized Cell Therapeutic Market Restraints
Table 210. Personalized Cell Therapeutic Distributors List
Table 211. Personalized Cell Therapeutic Downstream Customers
Table 212. Research Programs/Design for This Report
Table 213. Key Data Information from Secondary Sources
Table 214. Key Data Information from Primary Sources
List of Figures
Figure 1. Personalized Cell Therapeutic Product Picture
Figure 2. Global Personalized Cell Therapeutic Market Size, 2018 VS 2022 VS 2033 (US$ Million)
Figure 3. Global Personalized Cell Therapeutic Market Size Status and Outlook (2018-2033) & (US$ Million)
Figure 4. Global Personalized Cell Therapeutic Sales Status and Outlook (2018-2033) & (K Units)
Figure 5. Product Picture of Embryonic Stem Cells
Figure 6. Global Embryonic Stem Cells Sales YoY Growth (2018-2033) & (K Units)
Figure 7. Product Picture of Adult Stem Cell
Figure 8. Global Adult Stem Cell Sales YoY Growth (2018-2033) & (K Units)
Figure 9. Product Picture of Induced Pluripotent Cells
Figure 10. Global Induced Pluripotent Cells Sales YoY Growth (2018-2033) & (K Units)
Figure 11. Product Picture of Other
Figure 12. Global Other Sales YoY Growth (2018-2033) & (K Units)
Figure 13. Global Personalized Cell Therapeutic Sales by Type (2018-2033) & (US$ Million)
Figure 14. Global Personalized Cell Therapeutic Sales Market Share by Type in 2022 & 2033
Figure 15. North America Personalized Cell Therapeutic Sales Market Share in Volume by Type in 2022
Figure 16. North America Personalized Cell Therapeutic Sales Market Share in Value by Type in 2022
Figure 17. Europe Personalized Cell Therapeutic Sales Market Share in Volume by Type in 2022
Figure 18. Europe Personalized Cell Therapeutic Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific Personalized Cell Therapeutic Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific Personalized Cell Therapeutic Sales Market Share in Value by Type in 2022
Figure 21. Latin America Personalized Cell Therapeutic Sales Market Share in Volume by Type in 2022
Figure 22. Latin America Personalized Cell Therapeutic Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa Personalized Cell Therapeutic Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa Personalized Cell Therapeutic Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Personalized Cell Therapeutic Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Personalized Cell Therapeutic Revenue in 2022
Figure 27. Personalized Cell Therapeutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 28. Product Picture of Cardiovascular Diseases
Figure 29. Global Cardiovascular Diseases Sales YoY Growth (2018-2033) & (K Units)
Figure 30. Product Picture of Neurological Disorders
Figure 31. Global Neurological Disorders Sales YoY Growth (2018-2033) & (K Units)
Figure 32. Product Picture of Diabetes
Figure 33. Global Diabetes Sales YoY Growth (2018-2033) & (K Units)
Figure 34. Product Picture of Oncology
Figure 35. Global Oncology Sales YoY Growth (2018-2033) & (K Units)
Figure 36. Product Picture of Other
Figure 37. Global Other Sales YoY Growth (2018-2033) & (K Units)
Figure 38. Global Personalized Cell Therapeutic Sales by Application (2018-2033) & (US$ Million)
Figure 39. Global Personalized Cell Therapeutic Sales Market Share by Application in 2022 & 2033
Figure 40. North America Personalized Cell Therapeutic Sales Market Share in Volume by Application in 2022
Figure 41. North America Personalized Cell Therapeutic Sales Market Share in Value by Application in 2022
Figure 42. Europe Personalized Cell Therapeutic Sales Market Share in Volume by Application in 2022
Figure 43. Europe Personalized Cell Therapeutic Sales Market Share in Value by Application in 2022
Figure 44. Asia-Pacific Personalized Cell Therapeutic Sales Market Share in Volume by Application in 2022
Figure 45. Asia-Pacific Personalized Cell Therapeutic Sales Market Share in Value by Application in 2022
Figure 46. Latin America Personalized Cell Therapeutic Sales Market Share in Volume by Application in 2022
Figure 47. Latin America Personalized Cell Therapeutic Sales Market Share in Value by Application in 2022
Figure 48. Middle East and Africa Personalized Cell Therapeutic Sales Market Share in Value by Application in 2022
Figure 49. Key Raw Materials Price
Figure 50. Personalized Cell Therapeutic Manufacturing Cost Structure
Figure 51. Personalized Cell Therapeutic Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed